Suppr超能文献

神经母细胞瘤的消退与进展。遗传学能否预测肿瘤行为?

Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?

作者信息

Ambros P F, Ambros I M, Strehl S, Bauer S, Luegmayr A, Kovar H, Ladenstein R, Fink F M, Horcher E, Printz G

机构信息

CCRI, St Anna Kinderspital, Vienna, Austria.

出版信息

Eur J Cancer. 1995;31A(4):510-5. doi: 10.1016/0959-8049(95)00044-j.

Abstract

Neuroblastoma (NB) is a heterogeneous disease. The clinical course may range from spontaneous regression and maturation to very aggressive behaviour. Stage 4s is a unique subcategory of NB, generally associated with good prognosis, despite skin and/or liver involvement and the frequent presence of tumour cells in the bone marrow. Another type of NB is the locally invasive tumour without bone and bone marrow involvement which can also have a good prognosis, irrespective of lymph node involvement. Unfortunately, there is only limited biological information on such tumours which have not been treated with cytotoxic therapy despite lymph node involvement, residual tumour mass after surgery and/or bone marrow infiltration. In order to find specific genetic changes common to NBs with a benign clinical course, we studied the genetic abnormalities of these tumours and compared them with highly aggressive tumours. We analysed a series of 54 localised and stage 4s tumours by means of in situ hybridisation performed on fresh cells or on paraffin embedded tissues. In addition, we performed classical cytogenetics, Southern blotting and PCR analysis on fresh tumour tissue. The majority of patients had been treated with surgery alone, and in a number of patients tumour resection was incomplete. Deletions at 1p36 and amplifications of the MYCN oncogene were absent, and diploidy or tetraploidy were not seen in any case, with residual localised tumours possessing a favourable outcome. Unexpectedly, one patient with a tetraploid 4s tumour without any genetic structural changes not receiving any cytotoxic treatment, did well. Interestingly, this genetic spectrum contrasted with that of progressing tumours, in which most had genetic aberrations, the deletion at 1p36 being the most common event. These data, although limited, suggest that an intact 1p36 (recognised by D1Z2), the absence of MYCN amplification and near-triploidy (at least in localised tumours), represent prerequisites for spontaneous regression and/or maturation.

摘要

神经母细胞瘤(NB)是一种异质性疾病。其临床病程范围可从自发消退和成熟到极具侵袭性的行为。4s期是NB的一个独特亚类,尽管有皮肤和/或肝脏受累以及骨髓中频繁出现肿瘤细胞,但通常预后良好。另一种类型的NB是无骨骼和骨髓受累的局部侵袭性肿瘤,无论有无淋巴结受累,其预后也可能良好。遗憾的是,对于这些未经细胞毒性治疗的肿瘤,尽管存在淋巴结受累、术后残留肿瘤肿块和/或骨髓浸润,但相关生物学信息有限。为了找到临床病程良性的NB共有的特定基因变化,我们研究了这些肿瘤的基因异常,并将其与高度侵袭性肿瘤进行比较。我们通过对新鲜细胞或石蜡包埋组织进行原位杂交,分析了一系列54例局限性和4s期肿瘤。此外,我们还对新鲜肿瘤组织进行了经典细胞遗传学、Southern印迹和PCR分析。大多数患者仅接受了手术治疗,部分患者肿瘤切除不完全。未发现1p36缺失和MYCN癌基因扩增,且未观察到任何病例出现二倍体或四倍体,残留局限性肿瘤预后良好。出乎意料的是,一名患有四倍体4s肿瘤且无任何基因结构变化且未接受任何细胞毒性治疗的患者情况良好。有趣的是,这种基因谱与进展性肿瘤形成对比,进展性肿瘤大多存在基因畸变,1p36缺失是最常见的事件。这些数据虽然有限,但表明完整的1p36(由D1Z2识别)、无MYCN扩增和近三倍体(至少在局限性肿瘤中)是自发消退和/或成熟的先决条件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验